002923.SZ
润都股份
SZSE · Healthcare · C 制造业 · CN
CNY 10.88
−3.55%Year over year
Reported trailing growth
- Revenue
- +12.3%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -22.4%
- Operating cash flow
- -32.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -5.0%
- EBITDA
- -27.9%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -33.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026